by Mark S. King | May 10, 2019 | Living with HIV/AIDS, My Fabulous Disease, News, Prevention and Policy, Trump
Gilead Sciences, the pharmaceutical that makes Truvada, the only FDA-approved drug for PrEP, is having a great week in the public relations department. First, Gilead announced they were surrendering their patent for Truvada a year early, and now Federal... 
by Mark S. King | Apr 2, 2019 | My Fabulous Disease, News, Prevention and Policy, Trump
Advocates pressuring the Centers for Disease Control and Prevention (CDC) to claim royalties from sales of ‘Truvada as PrEP’ report “strong interest” in congressional hearings on the growing controversy, based on visits to the Hill today between HIV advocates and... 
by Mark S. King | Mar 30, 2019 | Living with HIV/AIDS, My Fabulous Disease, News, Prevention and Policy, Trump
You are going to read this story and think it is too outrageous to be true. You would be wrong. And, especially if you are an HIV advocate attending AIDS Watch in Washington, DC, this week, you must demand that our elected officials answer for it. Here’s the... 
by Mark S. King | Feb 25, 2019 | Living with HIV/AIDS, My Fabulous Disease, News, Prevention and Policy, Trump
(I DISAVOW THIS EDITORIAL ENTIRELY, DUE TO THE UNDUE INFLUENCE OF GILEAD PHARMACEUTICALS ON THE EDITORIAL PROCESS. YOU CAN READ MY STORY ABOUT THIS HERE. This Op-Ed appeared in The Washington Blade on February 22, 2019.) When I was diagnosed with HIV in 1985, there... 
by Mark S. King | Feb 7, 2019 | Gay Life, Living with HIV/AIDS, My Fabulous Disease, News, Prevention and Policy, Trump
Today is National Black HIV/AIDS Awareness Day, so let’s hear it for the Trump USA team behind his master race plan to end the HIV epidemic by 2030. I’ve even included an actual photo of their meeting on January 6th with a diverse group of stakeholders. Oh, wait.... 
by Mark S. King | Dec 19, 2018 | Living with HIV/AIDS, My Fabulous Disease, News, Prevention and Policy, Trump
The breaking point has been reached. After months of activism that has failed to convince the International AIDS Society (IAS) to withdraw their “AIDS2020” conference from San Francisco, activists have now announced an alternative conference, “HIV2020,” to be held in...
